Oral mucositis induced by anticancer treatments: physiopathology and treatments
- PMID: 18360589
- PMCID: PMC1661654
- DOI: 10.2147/tcrm.2006.2.2.159
Oral mucositis induced by anticancer treatments: physiopathology and treatments
Abstract
Oral mucositis is a frequent and devastating side effect of anticancer treatments. It impairs the patient's quality of life and also can be life threatening because severe infections and delayed or incomplete anticancer treatments may result. This problem has been largely overlooked and underestimated in the past. However, recently studies have been performed to precisely identify the epidemiology, cost, consequences, physiopathology, and treatments of oral mucositis. Clinical guidelines have recently been published to help the daily management of this frequent complication. In addition, some innovative new drugs, including palifermin, have been developed to prevent and treat this major side effect of cancer treatments. In this paper we summarize the recent developments of oral mucositis management.
Figures
References
-
- Anderson PM, Schroeder G, Skubitz KM. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer. 1998;83:1433–9. - PubMed
-
- Anderson PM, Ramsay NK, Shu XO, et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 1998;22:339–44. - PubMed
-
- Andriea-Abadic N, Levade T. Sphingomyelin hydrolysis during apoptosis. Biochem Biophys Acta. 2002;1585:126–34. - PubMed
-
- auf dem Keller U, Krampert M, Kümin A, et al. Keratinocyte growth factor: effects on keratinocytes and mechanisms of action. Eur J Biol. 2004;83:607–12. - PubMed
-
- Balducci L, Exterrman M. Management of cancer in the older person: a practical approach. Oncologist. 2000;20:224–37. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
